Featured SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide The drug was as good as a proven GLP-1, giving doctors another potent option for patients with type 2 diabetes and atherosclerotic cardiovascular disease. By Michael O'Riordan December 18, 2025